X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3201) 3201
Publication (218) 218
Book Review (32) 32
Newsletter (12) 12
Book Chapter (7) 7
Magazine Article (2) 2
Conference Proceeding (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (1967) 1967
animals (1959) 1959
desipramine (1501) 1501
desipramine - pharmacology (1475) 1475
rats (1426) 1426
humans (1065) 1065
pharmacology & pharmacy (914) 914
neurosciences (877) 877
female (831) 831
psychiatry (617) 617
antidepressants (516) 516
index medicus (516) 516
adult (506) 506
dose-response relationship, drug (414) 414
norepinephrine - metabolism (414) 414
depression (412) 412
antidepressive agents - pharmacology (382) 382
rats, sprague-dawley (369) 369
mice (349) 349
middle aged (337) 337
rats, inbred strains (326) 326
time factors (326) 326
imipramine (324) 324
fluoxetine (317) 317
desipramine - therapeutic use (313) 313
serotonin (258) 258
norepinephrine (247) 247
brain (246) 246
antidepressive agents, tricyclic - pharmacology (239) 239
clinical neurology (236) 236
brain - metabolism (231) 231
rats, wistar (225) 225
noradrenaline (222) 222
in vitro techniques (216) 216
fluoxetine - pharmacology (214) 214
dopamine (209) 209
adrenergic uptake inhibitors - pharmacology (208) 208
behavior, animal - drug effects (206) 206
motor activity - drug effects (206) 206
brain - drug effects (205) 205
adolescent (204) 204
antidepressant (203) 203
desipramine - administration & dosage (202) 202
depressive disorder - drug therapy (201) 201
double-blind method (199) 199
tricyclic antidepressants (191) 191
kinetics (190) 190
rat (189) 189
treatment outcome (183) 183
analysis of variance (181) 181
serotonin - metabolism (181) 181
drugs (178) 178
disease models, animal (175) 175
analysis (168) 168
major depression (168) 168
double-blind (167) 167
imipramine - pharmacology (167) 167
amitriptyline (165) 165
desipramine - blood (165) 165
dopamine - metabolism (165) 165
aged (158) 158
drug interactions (157) 157
biochemistry & molecular biology (155) 155
antidepressive agents, tricyclic - therapeutic use (152) 152
desipramine - metabolism (140) 140
forced swimming test (137) 137
antidepressive agents - therapeutic use (136) 136
rat-brain (135) 135
cocaine (132) 132
depression, mental (131) 131
swimming (131) 131
research (130) 130
child (128) 128
serotonin uptake inhibitors - pharmacology (128) 128
brain chemistry - drug effects (127) 127
depression - drug therapy (125) 125
tritium (125) 125
behavioral sciences (124) 124
neurons - drug effects (123) 123
stress (120) 120
article (118) 118
hippocampus - drug effects (113) 113
neurons (111) 111
behavior (109) 109
electric stimulation (108) 108
norepinephrine - analysis (108) 108
reserpine - pharmacology (108) 108
drug therapy (107) 107
norepinephrine - pharmacology (103) 103
receptors (102) 102
cocaine - pharmacology (99) 99
depressive disorder - psychology (99) 99
anxiety (97) 97
cerebral cortex - metabolism (96) 96
psychiatric status rating scales (94) 94
inhibition (92) 92
norepinephrine - physiology (92) 92
clomipramine (89) 89
heart rate - drug effects (89) 89
hippocampus - metabolism (89) 89
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3192) 3192
German (10) 10
French (4) 4
Japanese (4) 4
Spanish (4) 4
Russian (3) 3
Chinese (1) 1
Italian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10047, pp. 881 - 890
Summary Background Major depressive disorder is one of the most common mental disorders in children and adolescents. However, whether to use pharmacological... 
Internal Medicine | TRIALS | MEDICINE, GENERAL & INTERNAL | ACCEPTABILITY | MENTAL-HEALTH-CARE | TRENDS | GUIDELINES | Mianserin - adverse effects | Triazoles - administration & dosage | Triazoles - adverse effects | Humans | Citalopram - adverse effects | Sertraline - adverse effects | Venlafaxine Hydrochloride - adverse effects | Imipramine - administration & dosage | Paroxetine - adverse effects | Mianserin - analogs & derivatives | Paroxetine - administration & dosage | Desipramine - adverse effects | Nortriptyline - administration & dosage | Nortriptyline - adverse effects | Mianserin - administration & dosage | Child | Fluoxetine - adverse effects | Depressive Disorder, Major - drug therapy | Clomipramine - administration & dosage | Duloxetine Hydrochloride - adverse effects | Double-Blind Method | Drug Administration Schedule | Treatment Outcome | Clomipramine - adverse effects | Evidence-Based Medicine | Desipramine - administration & dosage | Randomized Controlled Trials as Topic | Venlafaxine Hydrochloride - administration & dosage | Citalopram - administration & dosage | Confounding Factors (Epidemiology) | Sertraline - administration & dosage | Adolescent | Amitriptyline - adverse effects | Bayes Theorem | Fluoxetine - administration & dosage | Duloxetine Hydrochloride - administration & dosage | Antidepressive Agents - administration & dosage | Antidepressive Agents - adverse effects | Research Design | Amitriptyline - administration & dosage | Imipramine - adverse effects | Psychological aspects | Medical colleges | Neurosciences | Drugs and youth | Rankings | Comparative analysis | Child psychopathology | Major depressive disorder | Antidepressants, Tricyclic | Pediatric pharmacology | Mental illness | Studies | Teenagers | Mental depression | Antidepressants | Meta-analysis | Children & youth
Journal Article
Journal of Child Psychology and Psychiatry, ISSN 0021-9630, 05/2008, Volume 49, Issue 5, pp. 489 - 498
Objective:  To conduct a meta‐analysis on randomized, controlled treatment trials of pediatric obsessive‐compulsive disorder (OCD). Method:  Studies were... 
cognitive‐behavioral therapy | drug therapy | pharmacology | Child/adolescent obsessive‐compulsive disorder | meta‐analysis | psychotherapy | pediatric | Child/adolescent obsessive-compulsive disorder | Psychotherapy | Pharmacology | Cognitive-behavioral therapy | Drug therapy | Pediatric | Meta-analysis | child/adolescent obsessive-compulsive disorder | CLOMIPRAMINE TREATMENT | PSYCHIATRY | PSYCHOLOGY, DEVELOPMENTAL | meta-analysis | cognitive-behavioral therapy | CHILDHOOD | FLUOXETINE | CHILDREN | MULTICENTER TRIAL | DESIPRAMINE | ADOLESCENTS | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | BEHAVIORAL TREATMENT | Pediatrics | Behavior Disorders | Behavior Modification | Drug Therapy | Cognitive Restructuring | Outcomes of Treatment | Comparative Analysis | Child Behavior | Effect Size | Literature Reviews | Meta Analysis | Counseling Effectiveness | Antisocial Behavior | Counseling Techniques | Obsessive-Compulsive Disorder - drug therapy | Drug Therapy - methods | Humans | Obsessive-Compulsive Disorder - therapy | Adolescent | Adult | Cognitive Therapy | Combined Modality Therapy | Child | Randomized Controlled Trials as Topic | Psychological aspects | Cognitive therapy | Analysis | Youth | Teenagers | Obsessive-compulsive disorder | Behavioral assessment | Behavior | Research | Clinical trials | Child psychology | Neuroses | Psychiatry
Journal Article
Psychoneuroendocrinology, ISSN 0306-4530, 2013, Volume 38, Issue 9, pp. 1553 - 1564
Summary The prevalence of childhood obesity has risen dramatically and coincident with this upsurge is a growth in adverse childhood psychological conditions... 
Endocrinology & Metabolism | Psychiatry | Type 2 diabetes | Depressive-like behavior | Catechol-O-methyltransferase | Monoamine oxidase | Forced swim test | Indoleamine 2,3 dioxygenase | RODENTS | PSYCHIATRY | indoleamine 2,3 dioxygenase | NEUROSCIENCES | COGNITIVE FUNCTION | CHILDREN | DIABETES-MELLITUS | WHEEL | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | OBESITY | ENDOCRINOLOGY & METABOLISM | DOPAMINE | HYPERTENSION | BRAIN | Brain-Derived Neurotrophic Factor - genetics | Central Nervous System Stimulants - pharmacology | Overnutrition - physiopathology | Hippocampus - chemistry | Learning Disorders - prevention & control | Body Weight - drug effects | Motor Activity - drug effects | Male | Anxiety - prevention & control | Indoleamine-Pyrrole 2,3,-Dioxygenase - deficiency | Hippocampus - drug effects | Cerebral Cortex - physiopathology | Desipramine - pharmacology | Central Nervous System Stimulants - therapeutic use | Exploratory Behavior - drug effects | Antidepressive Agents - pharmacology | Brain-Derived Neurotrophic Factor - biosynthesis | Cerebral Cortex - drug effects | Cytokines - genetics | Dopamine - analysis | Homovanillic Acid - analysis | Cerebral Cortex - chemistry | Monoamine Oxidase - analysis | Reboxetine | Dietary Fats - adverse effects | Overnutrition - psychology | Blood Glucose - analysis | Morpholines - pharmacology | Methylphenidate - pharmacology | Maze Learning - drug effects | 3,4-Dihydroxyphenylacetic Acid - analysis | Mice, Knockout | Gene Expression Regulation - drug effects | Learning Disorders - chemically induced | Memory Disorders - prevention & control | Animals | Recognition (Psychology) - drug effects | Methylphenidate - therapeutic use | Mice | Receptors, Interleukin-1 Type I | Hippocampus - physiopathology | Physical Endurance - drug effects | Anxiety - etiology | Cytokines - biosynthesis | Memory Disorders - chemically induced | Stimulants | catechol-O-methyltransferase | depressive-like behavior | type 2 diabetes | monoamine oxidase | forced swim test
Journal Article